Fish A F
Department of Adult Health and Illness Nursing, Ohio State University, Columbus.
J Cardiovasc Nurs. 1994 Jul;8(4):57-71. doi: 10.1097/00005082-199407000-00006.
Angiotensin II, a known vasopressor agent, recently has been implicated as a growth factor in the heart and vascular smooth muscle. Angiotensin converting enzyme (ACE) inhibitors, which block angiotensin II synthesis, have been found to prevent or reverse cellular growth in the heart and vasculature--a novel mechanism of action. Further study is required to determine the precise mechanisms through which angiotensin II promotes growth as well as the mechanisms through which ACE inhibitors block growth. Large scale clinical trials are needed to delineate further the effectiveness of ACE inhibitors in humans, especially regarding vascular smooth muscle growth.
血管紧张素II是一种已知的血管加压剂,最近被认为是心脏和血管平滑肌中的一种生长因子。血管紧张素转换酶(ACE)抑制剂可阻断血管紧张素II的合成,已发现其能预防或逆转心脏和血管中的细胞生长——这是一种新的作用机制。需要进一步研究以确定血管紧张素II促进生长的精确机制以及ACE抑制剂阻断生长的机制。需要进行大规模临床试验,以进一步阐明ACE抑制剂对人类的有效性,特别是在血管平滑肌生长方面。